Hepatic veno-occlusive disease induced by Gymura segetum: Report of two cases

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 3, 2006, Pages 406-408

  Dai, Hui Fen ^a   Gao, Yuan ^a   Yang, Ming ^a   Yu, Chao Hui ^a   Gu, Zhu Ying ^a   Chen, Wei Xing ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Ascites; Chinese herbal; Drugs; Hepatic veno occlusive disease; Liver transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; CA 125 ANTIGEN; GYMURA SEGETUM EXTRACT; PANAX NOTOGINSENG EXTRACT; PLANT EXTRACT; PYRROLIZIDINE ALKALOID; TUBERCULIN; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ADULT; ARTICLE; ASCITES; CASE REPORT; CHINA; CLINICAL FEATURE; COLONOSCOPY; CONVALESCENCE; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; ECHOGRAPHY; FATIGUE; FEMALE; GASTROSCOPY; HEPATOMEGALY; HERBAL MEDICINE; HOSPITAL ADMISSION; HUMAN; INJURY; LABORATORY TEST; LIVER BIOPSY; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; LIVER VENOOCCLUSIVE DISEASE; MALE; MORTALITY; PARACENTESIS; PHYSICAL EXAMINATION; RURAL AREA;

ADULT; DRUGS, CHINESE HERBAL; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MALE; MIDDLE AGED;

EID: 33748055097     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jeliffe DB, Bras G, Stuart KL. Veno-occlusive disease of the liver. Pediatrics 1954;14:334-339.
2. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, et al. Veno-lccousive disease of the liver and multiorgan failure after marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993;118:225-267.
3. Ho V, Momtaz P, Didas C, Wadleigh M, Richardson P. Post-transplant hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Rev Clin Exp Hematol 2004; 8: E3.
4. Cheng Y, Liang D, Zhan Y. Morphological and histological studies of Herba Sedum aizoon. Zhong Yao Cai 2001;24: 330-332.
5. Hill KR. Serous hepatosis: a pathogenesis of hepatic fibrosis in Jamaican children. Br Med J 1953;1:117-122.
6. DeLeve LD, McCuskey RS, Wang X, Hu L, McCuskey MK, Epstein RB, et al. Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 1999; 29:1779-1791.
7. Zuckerman M, Steenkamp V, Stewart MJ. Hepatic venoocclusive disease as a result of a traditional remedy: confirmation of toxic pyrrolizidine alkaloids as the cause, using an in vitro technique. J Clin Pathol 2002;55:676-679.
8. Carreras E, Bertz H, Arcese W, Vernant JP, Tomas JF, Hagglund H, et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 1998;92:3599-3604.
9. Vassal G, Koscielny S, Challine D, Valteau Couanet D, Boland I, Deroussent A, et al. Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation. Cancer Chemother Pharmacol 1996;37:247-253.
10. Ozkaynak MF, Weinberg K, Kohn D, Sender L, Parkman R, Lenarsky C. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991;7: 467-474.
11. Leroy B, Le Franc P, Thomas P, Colombel F, Scherpereel P. Hepatic veno-occlusive disease caused by Deticene: a cause of acute hypovolemic shock. Ann Fr Anesth Reanim 1990; 9:550-552.
12. Holtmann M, Schreiner O, Kohler H, Denzer U, Neurath M, Galle PR, et al. Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathinprine. Dig Dis Sci 2003;48: 1503-1505.
13. Shulman HM, Gown AM, Nugent DJ. Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987;127:549-558.
14. Richardson PG, Murakami C, Jin Z, Warren D, Momtaz P, Hoppensteadt D, et al. Multi-institutonal use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002; 100:4337-4343.
15. Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D, et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004;33:189-195.
16. Kim ID, Egawa H, Marui Y, Kaihara S, Haga H, Lin YW, et al. A successful liver transplantation for refractory hepatic veno-occlusive disease originating from cord blood transplantation. Am J Transplant 2002;2:796-800.